Conclusion first: Policosanol remains scientifically interesting, but the evidence is mixed. A 2025 systematic review identified 45 eligible studies; newer randomized data reported blood-pressure and lipid improvements, while earlier independent trials found no significant cholesterol benefit. The better question is which material, dose, population and study design produced the result?
.jpg)
The review screened 528 records and included 45 studies: 19 randomized trials, 9 comparative studies, 9 nutraceutical studies, while 8 reported no significant effect. Importantly, its search ended in April 2024, so newer 2025 hypertension data were not included.
In a Cuban multicenter trial, 200 prehypertensive participants received placebo or 20 mg/day sugarcane-wax alcohols for 12 weeks. 44% reached an SBP reduction ≥10 mmHg versus 7% with placebo. The Grade I hypertension stratum later reported 74% versus 12%.
| Evidence | Key result | Meaning |
|---|---|---|
| 2025 systematic review | 45 studies; positive and null findings | Large but heterogeneous evidence base. |
| 2025 prehypertension stratum | 44% vs 7% reached ≥10 mmHg SBP reduction | New positive signal. |
| 2006 German RCT | 143 patients; 10–80 mg/day; no lipid benefit vs placebo | Results are not universally reproducible. |
A German randomized trial found no significant LDL-C benefit at 10–80 mg/day, and other independent studies also reported null lipid results. This challenges the idea that every “Policosanol” product is clinically interchangeable.
Composition may contribute, but cannot explain everything. Policosanol is a mixture of long-chain primary alcohols, commonly including C24, C26, C28 and C30. Food Chemistry research showed source-dependent profiles and found some supplements containing less total Policosanol than claimed.
.jpg)
This is why Octacosanol is not synonymous with Policosanol: C28 may be a major constituent, but Policosanol is a mixture. Compositional consistency therefore matters.
HUZHOU SIFENG BIOCHEM CO., LTD focuses on plant high-carbon fatty alcohols. Its SF-001 Policosanol is supplied under CAS 142583-61-7. Our related article on Policosanol, Octacosanol and Triacontanol explains why separation and homolog control matter in industrial production.
Share your target source, analytical profile, annual volume and destination market. We can discuss SF-001 documentation and sample evaluation while keeping finished-product efficacy claims separate from raw-material specifications.
HUZHOU SIFENG BIOCHEM CO., LTD · SF-001 Policosanol
